After Werner finished speaking, the blonde Karin Kneiser next to him took out a document and placed it on the table.
Park Jin Hyuk took the document, looked at it, and then handed it to Mao Dayong.
"I'm not an expert, so you should confirm it."
While Mao Dayong was reading the document, Park Jin Hyuk said:
"When do you plan to conduct Phase 3 clinical trials?"
"The FDA usually gives results within 30 days, and we hope to restart the Phase 3 trial as soon as possible."
"You want us to produce experimental drugs, right?"
The three people from North Company looked at each other.
Their communication with other companies always ended at this stage.
The trial of the prostate cancer drug they developed was suspended in the Phase III clinical stage due to questions raised by the FDA. After learning about this situation, everyone rejected their production request.
North Corporation has run out of funds. If it wants to restart the experiment, it will need to invest tens of billions of dollars, which North Corporation cannot afford.
'We hope to be able to meet the FDA's production capacity requirements.'
After hearing the other party's answer, Park Jin Hyuk looked at Mao Dayong.
Mao Dayong explained to Park Jin Hyuk:
“When the FDA approves new drugs, it considers production capacity. If the corresponding production capacity is not available, even the best drug will not be approved.”
"That is, when North submits its application for its new drug to the FDA, it hopes to use DS BilLogics as proof of its production capacity."
“That’s true, but the problem is that when evaluating production capacity, the FDA not only has to review documents but also requires submission of the actual drugs produced.”
“If we ultimately fail to obtain FDA approval, won’t the drug we produce be useless?”
"That's right."
Park Jin Hyuk roughly understood what was going on and nodded.
The three people opposite couldn't understand what they were saying and looked at them anxiously.
Park Jin Hyuk smiled at them.
"Even if the FDA allows you to submit additional data, a Phase III clinical trial requires tens of billions of dollars in investment. Where will you get the money?"
The three of them were speechless again at this question.
Because the funds have not yet been found.
"What do you think?"
Park Jin Hyuk turned and asked Mao Dayong.
“I suggest we discuss this further.”
"Further discussion? In other words, this thing is not completely impossible to do?"
Mao Dayong did not answer.
When he first entered the cafe, he was still distrustful of these three people.
But after reading their relevant documents, he found that the content was written like a research paper and was relatively rigorous.
Documents show that the suspension of the Phase III clinical trial was caused by an incidental problem.
So he asked the other party:
"According to the documents, the raw materials you used are completely different from those used in existing drugs. Could you further explain the preparation process of the raw materials and whether there is any precedent for their use? The FDA has also raised the same question. Could you please show us the application materials you submitted to the FDA to restart clinical trials?"
Mao Dayong had been reading documents and didn't say anything.
Then he spoke, and Werner said to him:
"Excuse me, are you Mr. Mao Dayong, the former director of Pfizer's German Research Institute?"
"Do you know me?"
"Yes, I also worked at the German Institute, but not for long. My name is Werner Bettenbauer. Do you remember me?"
"Bedenbauer?"
Mao Dayong thought hard, and then he seemed to remember something.
"I remember you didn't have a beard before, but now you have one. You worked at the German research institute for a short time before you quit. Did you start your own business?"
"Yes, that's great! You still remember me, so it will be easy to communicate."
The three of them began an in-depth conversation with Mao Dayong about their products.
Because they all worked in medical research, their conversation was interspersed with various professional and difficult-to-understand vocabulary.
Park Jin Hyuk did not interrupt, but listened quietly and asked Kim Jun Woo to briefly translate their conversation to him.
After a thorough discussion with the three, Mao Dayong said to Park Jin Hyuk:
"I don't think there are any major problems with the drugs they develop."
"Oh? What are the chances of success?"
"The possibility is still very high. However, the problem is... they are out of money. If the funding issue can be resolved, they should be able to obtain FDA approval. They had already prepared the supplementary materials, but the US federal government shutdown happened, so they only submitted them in the past two days. Based on our previous conversation, I believe the Phase III clinical trial should be approved."
"So that's how it is? So, they need to find a company to commission production as soon as possible."
Park Jin Hyuk put his hands on his chest and looked at the three people from North Company.
They also looked at Park Jin Hyuk and Mao Dayong with anticipation.
It can be seen from these three people that they are all R&D personnel and have never done marketing work before.
They had been running around at the exhibition for two weeks, and now they finally found someone who was willing to communicate with them in depth.
Park Jin Hyuk asked his question with a smile.
“I want to know, how much investment do you need?”
After hearing Park Jin Hyuk's question, the three were stunned, because they only wanted to find a factory willing to produce drugs for them.
Even Mao Dayong and Jin Junyu were surprised.
"Director Park, is DS Pharmaceuticals planning to invest?"
"No, you translated it for them. It's my personal idea to invest in them."
Kim Jun-woo hesitated for a moment, but still translated Park Jin-hyuk's words to the other party.
And told the other party that Park Jin Hyuk is the heir to DS Group.
In the industry, although DS Pharmaceuticals is not well-known, DS Heavy Industries is a world-renowned company.
After learning that DS Pharmaceuticals and DS Heavy Industries were both subsidiaries of the DS Group, and that the man in front of them was the heir to this huge group, the three people looked as if they had found a savior.
"To complete Phase III clinical trials, we'll need another $20 million in investment. We'll also need to conduct pilot production and Phase I drug production... How much can you invest?"
Park Jin Hyuk nodded and picked up the documents on the table.
"Can you give us this information?"
The other party nodded quickly.
Park Jin Hyuk handed the information to Kim Jun Woo and stood up.
"20 million US dollars? I'll think about it when I get back. We'll also seriously study the matter of entrusting DS Pharmaceuticals with production."
"After the research is completed, you will inform us of the results, right?"
Werner stood up and asked anxiously.
He had already seen hope, but he was worried that all this would come to nothing.
Continue read on readnovelmtl.com
